First, tumor bearing mice in which caspase 3/7 expression was ablated specifically in intestinal epithelial cells (IEC) (Casp3/7ΔIEC) failed to respond to OXA while RIPK3-deficient animals disabled for necroptosis of the IEC controlled tumor outgrowth during OXA therapy (26). The gene discussed is RIPK3; the disease is neoplasm.